易加科技 PLUS
$92.11 +$9.68 (+11.74%)
休市 · Nov 7, 7:10 am ET · 最新盘后价 $92.11 0.00%
开盘$85.69
昨收$82.43
当日区间$85.68 – $95.35
成交量443.9K
市值$2.39B
市盈率（TTM）19.1
股息率1.13%
PLUS 相关新闻
匹配 ePlus 或代码 PLUS 的头条新闻，按最新排序。
- Deutsche Bank Initiates CANAL PLUS SA(CNALF.US) With Buy Rating, Announces Target Price $4.47
- What Is EPlus Inc.'s (NASDAQ:PLUS) Share Price Doing?
- Nvidia Is Approaching a Breakout Level. Plus, What We Want to See From Micron
- William Blair Maintains EPlus(PLUS.US) With Buy Rating
- Scotiabank Maintains 5N PLUS INC(FPLSF.US) With Buy Rating, Raises Target Price to $26.1 正面
- 5N Plus Inc. Is Maintained at Sector Outperform by Scotia Capital 正面
- 5N Plus Inc. Price Target Raised to C$37.00/Share From C$35.00 by Scotia Capital 正面
- Ying'en Bio-B (09606.HK): Core product registrations and clinical progress are being steadily realized; the ADC plus second-generation IO combination therapy is highly anticipated.
- Truist Financial Maintains Travel Plus Leisure(TNL.US) With Buy Rating, Maintains Target Price $86
- Truist Financial Maintains Travel Plus Leisure(TNL.US) With Buy Rating, Announces Target Price $86
- Earnings Flash (PLUS) EPlus Inc. Reports Q1 Revenue $649.1M, Vs. FactSet Est of $640.0M
- Earnings Flash (PLUS) EPlus Inc. Posts Q1 Adjusted EPS $1.28 per Share, Vs. FactSet Est of $1.19
- Sungrow (300274): A leading player in solar-plus-storage is accelerating its AIDC deployment, with a steady stream of new products for large-scale energy storage, commercial applications, and industrial use.
- Lenovo Group (00992.HK): The cloud-plus-edge AI server upcycle continues, and ISG's profitability is expected to improve significantly.
- CanFang Bio (9926.HK): In a head-to-head Phase III trial in first-line biliary tract cancer, AK112 demonstrated significantly superior overall survival compared to durvalumab plus chemotherapy, further validating its potential.
暂无评论——快来第一个聊聊 PLUS。